Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” third-quarter 2024 ...

Apple has redefined what a watch can do. We talked to Apple’s top brains and other experts about the promises and perils of ...

Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

Obstructive sleep apnea is a condition that disrupts rest, leading to symptoms such as daytime fatigue, brain fog and headaches. In the long-term, untreated sleep apnea can have serious health ...

Sleep apnea involves repeated breathing interruptions during sleep, while loud snoring is steady and doesn’t typically affect breathing. A doctor can help confirm the difference. Sleep apnea is ...

Opens in a new tab or window The FDA approved tirzepatide (Zepbound) for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity, the agency announced late Friday. Used along with ...

Peer Support Could Help Millions With Sleep Apnea Slumber Easier ... New Guideline Provides Treatment Recommendations for Restless Legs Syndrome Nov. 13, 2024 — A new clinical practice guideline ...

Sleep apnea is known to wreak havoc with the body, contributing to heart problems, diabetes and liver disease. The sleep disorder also appears to have direct effects on brain health, a new study ...

Share on Pinterest A new study links sleep apnea to changes in key brain regions related to memory. Image credit: Maskot/Getty Images. About 936 million adults around the world have sleep apnea.

including snoring and obstructive sleep apnea. Obstructive sleep apnea is when a person stops breathing five or more times per hour. When breathing stops, it can lower oxygen levels, affecting the ...

Your tongue is a major component of your upper airway, and its size, structure, and function can be affected by — and contribute to — sleep apnea. Sleep apnea conditions cause pauses in your ...

The Food and Drug Administration approved Zepbound as the first prescription medicine to treat sleep apnea on Friday—marking a significant win for the drug company Eli Lilly, which had Zepbound ...